Global Musculoskeletal Disorders Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Parenteral and Oral), By Drug Type (Analgesics, DMARDs, Corticosteroids), By Regional Outlook and Forecast, 2023 - 2029

The Global Musculoskeletal Disorders Drugs Market size is expected to reach $109.4 billion by 2029, rising at a market growth of 4.2% CAGR during the forecast period.

Asia Pacific is one of the major contributors of the market as China, Japan, and India have aged population, thus capturing approximately 2/5^th share of the market by 2029. For instance, over 60% of Japan's population is aged 30 and above. By 2050, most of the global population aged 60 and above is projected to be in low- and middle-income nations. The rise in life expectancy has led to a growing aging population. This emerging trend is advantageous for the market as it leads to a rise in the incidence of musculoskeletal diseases due to the illness's high prevalence in old adults and boosts the demand for its treatments, resulting in market expansion.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2022, The Johnson & Johnson Medical Devices Companies collaborated with Microsoft for expanding its digital surgery ecosystem. In addition, Pfizer came into collaboration with Sirana Pharma focusing on investigating treatment for a rare bone disease, through leveraging Sirana’s microRNA targeting approach.

KBV Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson, Novartis AG, and Pfizer, Inc. are the forerunners in the Market. In March, 2022, Pfizer completed the acquisition of Arena Pharmaceuticals, an American biopharmaceutical company. Through this acquisition, the company aimed to adjoin the amazing pipeline and experience of Arena Pharmaceuticals to Pfizer’s Immunology and swelling healing area, assisting further motive of advancement boost to change the lives of patients with the immuno-inflammatory illness. Companies such as AbbVie, Inc., Amgen, Inc., and UCB S.A. are some of the key innovators in Market.

COVID-19 Impact Analysis

The COVID-19 pandemic caused supply chain disruptions in several end-user industries, including food and beverage, healthcare, and industrial. In addition, the COVID-19-led economic slowdown resulted in a drop in the market for musculoskeletal disorders drugs. Since the COVID-19 pandemic disrupted supply chains and slowed down clinical studies and drug development, it had a considerable effect on the market for medications for musculoskeletal problems. Due to a drop in sales of medications for musculoskeletal disorders, including analgesics, the market for musculoskeletal disorders drugs shrank during the period. However, a rebound in the market is forecasted, and the musculoskeletal disease medications market is expected to continue growing steadily in the years to come.

Market Growth Factors

Musculoskeletal diseases are extremely common

There are more than 150 diseases and conditions that are categorized as musculoskeletal impairments. These impairments are characterized by muscle, bone, joint, and adjacent connective tissue dysfunction. These dysfunctions can result in temporary or permanent restrictions on functioning and involvement. According to WHO, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as rheumatoid arthritis, osteoarthritis, low back pain, neck discomfort, fractures, and other injuries. Musculoskeletal problems afflict people of all ages; however, the prevalence differs by age and diagnosis. As more people suffer from musculoskeletal problems, there will likely be a greater need for pharmaceuticals to treat them, accelerating market expansion.

Higher alcohol consumption

At both the individual and societal levels, numerous variables that influence alcohol consumption levels, patterns, and the scope of alcohol-related issues in populations have been found. Poorer cultures experience more negative health effects and social implications from drinking at a given level and pattern of drinking than wealthier ones. Men account for 7.7% of all fatalities globally from alcohol-related causes, compared to women, who account for 2.6% of all deaths. In addition, male drinkers used 19.4 liters of pure alcohol on average per person in 2016, whereas female drinkers consumed 7.0 liters on average. As there is a link between higher rates of joint diseases and greater alcohol use, the market is anticipated to develop as a result of rising alcohol consumption throughout the projected period.

Market Restraining Factors

Insufficient availability of healthcare professionals

Projected for 2035, a shortage of 12.9 million healthcare professionals is anticipated, representing an increase from the current 7.2 million deficit. As per the recent research published by WHO, it has been observed that the dearth of healthcare professionals can significantly impact the health of billions of individuals globally if prompt action is not taken. Factors contributing to this phenomenon include an aging workforce, resulting in retirements or departures for higher-paying positions without corresponding replacements. Also, there is a shortage of new entrants and inadequate training in the industry. Insufficient healthcare personnel in different regions of the world will negatively impact the identification and management of ailments such as musculoskeletal disorders, reducing the need for associated medications and hindering market expansion.

Drug Type Outlook

Based on drug type, the market is segmented into analgesics, DMARDs, corticosteroids and others. The analgesics segment dominated the market with maximum revenue share in 2022. This is due to the affordability of analgesics, which is increasing their demand in the market as medications for musculoskeletal disorders. Additionally, they come in a variety of strengths, from moderate to powerful, and many of these are available over the counter at the local drugstore or grocery store. Thus, their affordability and availability as OTC is expected to boost the segment's expansion.

Distribution Channel Outlook

By distribution channel, the market is classified into hospital pharmacies, online providers and drug stores & retail pharmacies. The drug stores & retail pharmacies segment witnessed the largest revenue share in the market in 2022. This is due to a growth in the number of patients suffering from musculoskeletal ailments such as rheumatoid arthritis, which raises the demand for pharmaceuticals in drug stores and retail pharmacies. Also, these stores are able to provide a much more personalized solution to the customer's complication, and the patient can have their medication instantly. The easy availability of drugs, combined with other factors, is expected to increase the segment's growth.

Route of Administration Outlook

On the basis of route of administration, the market is divided into oral and parenteral. The oral segment procured a substantial revenue share in the market in 2022. This is owing to the fact many patients choose oral drugs over other kinds of treatment because they are easier to administer and less expensive. Due to its many benefits, the oral administration route is favored above the many alternative medication delivery methods. These benefits include dependability to accommodate different drug types, safety, excellent patient compliance, simplicity of intake, pain avoidance, and versatility. The benefits associated with the oral route will drive the market segment's expansion.

Musculoskeletal Disorders Drugs Market Report Coverage

Report Attribute	Details
Market size value in 2022	USD 82.4 Billion
Market size forecast in 2029	USD 109.4 Billion
Base Year	2022
Historical Period	2019 to 2021
Forecast Period	2023 to 2029
Revenue Growth Rate	CAGR of 4.2% from 2023 to 2029
Number of Pages	226
Number of Table	354
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Gender, Procedure, Application, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Higher alcohol consumption Musculoskeletal diseases are extremely common
Restraints	Insufficient availability of healthcare professionals

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the market in 2022. The market is expanding due to the presence of numerous key companies and improvements in the region's medicine production for musculoskeletal disorders. Additionally, the market is anticipated to develop due to a solid healthcare infrastructure, significant purchasing power, and an increased adoption rate of analgesics and other medications for musculoskeletal disorders. Additionally, there has been an increase in the prevalence of musculoskeletal illnesses due to several causes, such as obesity, sedentary lifestyles, and workplace injuries, which has led to a rise in the demand for medications to treat these conditions, propelling the market growth in the region.

Free Valuable Insights: Global Musculoskeletal Disorders Drugs Market size to reach USD 109.4 Billion by 2029

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Amgen, Inc., Eli Lilly And Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and UCB S.A.

Recent Strategies Deployed in the Market

» Partnerships, Collaborations and Agreements:

• Jun-2022: Pfizer came into collaboration with Sirana Pharma, a Germany-based developer of a biotechnology company. The collaboration involves investigating treatment for a rare bone disease, through leveraging Sirana’s microRNA targeting approach.
• Jan-2022: The Johnson & Johnson Medical Devices Companies collaborated with Microsoft, a US-based technology company. The collaboration involves expanding the medical devices company's digital surgery ecosystem.
• Feb-2021: UCB extended its collaboration agreement with Microsoft, a US-based technology company. The agreement involves advancing drug discovery and development. The collaboration integrates Microsoft's cloud, AI, computational services, and UCS's drug discovery abilities, and aims at identifying more effective molecules.

» Geographical Expansions:

• Sep-2022: AbbVie expanded its already existing facility located in Cork. The expansion includes building a new manufacturing facility and bringing in new technologies.

» Acquisitions and Mergers:

• Mar-2022: Pfizer completed the acquisition of Arena Pharmaceuticals, an American biopharmaceutical company. Through this acquisition, the company aimed to adjoin the amazing pipeline and experience of Arena Pharmaceuticals to Pfizer’s Immunology and swelling healing area, assisting further motive of advancement boost to change the lives of patients with the immuno-inflammatory illness.
• Mar-2022: UCB took over Zogenix, a US-based developer of therapeutic solutions. The addition of Zogenix expands and reinforces the acquiring company's market presence and reinforces its sustainable patient value strategy.
• Oct-2021: Amgen took over Teneobio, a clinical-stage biotechnology company. With this acquisition, the company aimed to leverage Teneobio's antibody platform to complement its prevailing capabilities. Moreover, the company also aimed to gain a diverse range of building blocks that can be created into new multispecific therapeutics.

» Approvals and Trials:

• Apr-2022: AbbVie received FDA clearance for its RINVOQ. RINVOQ is intended for the treatment of ankylosing spondylitis (AS) in adults. The recently approved drug delivers quick disease control. Further, the approval demonstrates the company's continued advancement towards achieving its mission to accelerate the standards of care in rheumatic diseases.

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Route of Administration

• Parenteral
• Oral

By Drug Type

• Analgesics
• DMARDs
• Corticosteroids
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Amgen, Inc.
• Eli Lilly And Company
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Musculoskeletal Disorders Drugs Market, by Distribution Channel
1.4.2 Global Musculoskeletal Disorders Drugs Market, by Route of Administration
1.4.3 Global Musculoskeletal Disorders Drugs Market, by Drug Type
1.4.4 Global Musculoskeletal Disorders Drugs Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Geographical Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Musculoskeletal Disorders Drugs Market by Distribution Channel
4.1 Global Drug Stores & Retail Pharmacies Market by Region
4.2 Global Hospital Pharmacies Market by Region
4.3 Global Online Providers Market by Region

Chapter 5. Global Musculoskeletal Disorders Drugs Market by Route of Administration
5.1 Global Parenteral Market by Region
5.2 Global Oral Market by Region

Chapter 6. Global Musculoskeletal Disorders Drugs Market by Drug Type
6.1 Global Analgesics Market by Region
6.2 Global DMARDs Market by Region
6.3 Global Corticosteroids Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Musculoskeletal Disorders Drugs Market by Region
7.1 North America Musculoskeletal Disorders Drugs Market
7.1.1 North America Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.1.1 North America Drug Stores & Retail Pharmacies Market by Country
7.1.1.2 North America Hospital Pharmacies Market by Country
7.1.1.3 North America Online Providers Market by Country
7.1.2 North America Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.2.1 North America Parenteral Market by Country
7.1.2.2 North America Oral Market by Country
7.1.3 North America Musculoskeletal Disorders Drugs Market by Drug Type
7.1.3.1 North America Analgesics Market by Country
7.1.3.2 North America DMARDs Market by Country
7.1.3.3 North America Corticosteroids Market by Country
7.1.3.4 North America Others Market by Country
7.1.4 North America Musculoskeletal Disorders Drugs Market by Country
7.1.4.1 US Musculoskeletal Disorders Drugs Market
7.1.4.1.1 US Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.4.1.2 US Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.4.1.3 US Musculoskeletal Disorders Drugs Market by Drug Type
7.1.4.2 Canada Musculoskeletal Disorders Drugs Market
7.1.4.2.1 Canada Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.4.2.2 Canada Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.4.2.3 Canada Musculoskeletal Disorders Drugs Market by Drug Type
7.1.4.3 Mexico Musculoskeletal Disorders Drugs Market
7.1.4.3.1 Mexico Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.4.3.2 Mexico Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.4.3.3 Mexico Musculoskeletal Disorders Drugs Market by Drug Type
7.1.4.4 Rest of North America Musculoskeletal Disorders Drugs Market
7.1.4.4.1 Rest of North America Musculoskeletal Disorders Drugs Market by Distribution Channel
7.1.4.4.2 Rest of North America Musculoskeletal Disorders Drugs Market by Route of Administration
7.1.4.4.3 Rest of North America Musculoskeletal Disorders Drugs Market by Drug Type
7.2 Europe Musculoskeletal Disorders Drugs Market
7.2.1 Europe Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.1.1 Europe Drug Stores & Retail Pharmacies Market by Country
7.2.1.2 Europe Hospital Pharmacies Market by Country
7.2.1.3 Europe Online Providers Market by Country
7.2.2 Europe Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.2.1 Europe Parenteral Market by Country
7.2.2.2 Europe Oral Market by Country
7.2.3 Europe Musculoskeletal Disorders Drugs Market by Drug Type
7.2.3.1 Europe Analgesics Market by Country
7.2.3.2 Europe DMARDs Market by Country
7.2.3.3 Europe Corticosteroids Market by Country
7.2.3.4 Europe Others Market by Country
7.2.4 Europe Musculoskeletal Disorders Drugs Market by Country
7.2.4.1 Germany Musculoskeletal Disorders Drugs Market
7.2.4.1.1 Germany Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.1.2 Germany Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.1.3 Germany Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.2 UK Musculoskeletal Disorders Drugs Market
7.2.4.2.1 UK Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.2.2 UK Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.2.3 UK Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.3 France Musculoskeletal Disorders Drugs Market
7.2.4.3.1 France Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.3.2 France Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.3.3 France Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.4 Russia Musculoskeletal Disorders Drugs Market
7.2.4.4.1 Russia Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.4.2 Russia Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.4.3 Russia Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.5 Spain Musculoskeletal Disorders Drugs Market
7.2.4.5.1 Spain Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.5.2 Spain Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.5.3 Spain Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.6 Italy Musculoskeletal Disorders Drugs Market
7.2.4.6.1 Italy Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.6.2 Italy Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.6.3 Italy Musculoskeletal Disorders Drugs Market by Drug Type
7.2.4.7 Rest of Europe Musculoskeletal Disorders Drugs Market
7.2.4.7.1 Rest of Europe Musculoskeletal Disorders Drugs Market by Distribution Channel
7.2.4.7.2 Rest of Europe Musculoskeletal Disorders Drugs Market by Route of Administration
7.2.4.7.3 Rest of Europe Musculoskeletal Disorders Drugs Market by Drug Type
7.3 Asia Pacific Musculoskeletal Disorders Drugs Market
7.3.1 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.1.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
7.3.1.2 Asia Pacific Hospital Pharmacies Market by Country
7.3.1.3 Asia Pacific Online Providers Market by Country
7.3.2 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.2.1 Asia Pacific Parenteral Market by Country
7.3.2.2 Asia Pacific Oral Market by Country
7.3.3 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type
7.3.3.1 Asia Pacific Analgesics Market by Country
7.3.3.2 Asia Pacific DMARDs Market by Country
7.3.3.3 Asia Pacific Corticosteroids Market by Country
7.3.3.4 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Musculoskeletal Disorders Drugs Market by Country
7.3.4.1 China Musculoskeletal Disorders Drugs Market
7.3.4.1.1 China Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.1.2 China Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.1.3 China Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.2 Japan Musculoskeletal Disorders Drugs Market
7.3.4.2.1 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.2.2 Japan Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.2.3 Japan Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.3 India Musculoskeletal Disorders Drugs Market
7.3.4.3.1 India Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.3.2 India Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.3.3 India Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.4 South Korea Musculoskeletal Disorders Drugs Market
7.3.4.4.1 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.4.2 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.4.3 South Korea Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.5 Singapore Musculoskeletal Disorders Drugs Market
7.3.4.5.1 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.5.2 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.5.3 Singapore Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.6 Malaysia Musculoskeletal Disorders Drugs Market
7.3.4.6.1 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.6.2 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.6.3 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type
7.3.4.7 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market
7.3.4.7.1 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel
7.3.4.7.2 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration
7.3.4.7.3 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type
7.4 LAMEA Musculoskeletal Disorders Drugs Market
7.4.1 LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.1.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
7.4.1.2 LAMEA Hospital Pharmacies Market by Country
7.4.1.3 LAMEA Online Providers Market by Country
7.4.2 LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.2.1 LAMEA Parenteral Market by Country
7.4.2.2 LAMEA Oral Market by Country
7.4.3 LAMEA Musculoskeletal Disorders Drugs Market by Drug Type
7.4.3.1 LAMEA Analgesics Market by Country
7.4.3.2 LAMEA DMARDs Market by Country
7.4.3.3 LAMEA Corticosteroids Market by Country
7.4.3.4 LAMEA Others Market by Country
7.4.4 LAMEA Musculoskeletal Disorders Drugs Market by Country
7.4.4.1 Brazil Musculoskeletal Disorders Drugs Market
7.4.4.1.1 Brazil Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.1.2 Brazil Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.1.3 Brazil Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.2 Argentina Musculoskeletal Disorders Drugs Market
7.4.4.2.1 Argentina Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.2.2 Argentina Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.2.3 Argentina Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.3 UAE Musculoskeletal Disorders Drugs Market
7.4.4.3.1 UAE Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.3.2 UAE Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.3.3 UAE Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.4 Saudi Arabia Musculoskeletal Disorders Drugs Market
7.4.4.4.1 Saudi Arabia Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.4.2 Saudi Arabia Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.4.3 Saudi Arabia Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.5 South Africa Musculoskeletal Disorders Drugs Market
7.4.4.5.1 South Africa Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.5.2 South Africa Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.5.3 South Africa Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.6 Nigeria Musculoskeletal Disorders Drugs Market
7.4.4.6.1 Nigeria Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.6.2 Nigeria Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.6.3 Nigeria Musculoskeletal Disorders Drugs Market by Drug Type
7.4.4.7 Rest of LAMEA Musculoskeletal Disorders Drugs Market
7.4.4.7.1 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel
7.4.4.7.2 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration
7.4.4.7.3 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Drug Type

Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.4 UCB S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Amgen, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Merck & Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Novartis AG
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Teva Pharmaceutical Industries Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses

TABLE 1 Global Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 2 Global Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Musculoskeletal Disorders Drugs Market
TABLE 4 geographical expansions – Musculoskeletal Disorders Drugs Market
TABLE 5 Acquisition and Mergers– Musculoskeletal Disorders Drugs Market
TABLE 6 Approvals and trials – Musculoskeletal Disorders Drugs Market
TABLE 7 Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 8 Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 9 Global Drug Stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 10 Global Drug Stores & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 11 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Online Providers Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Online Providers Market by Region, 2023 - 2029, USD Million
TABLE 15 Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 16 Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 17 Global Parenteral Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Parenteral Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Oral Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Oral Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 22 Global Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 23 Global Analgesics Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Analgesics Market by Region, 2023 - 2029, USD Million
TABLE 25 Global DMARDs Market by Region, 2019 - 2022, USD Million
TABLE 26 Global DMARDs Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Corticosteroids Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Corticosteroids Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Others Market by Region, 2023 - 2029, USD Million
TABLE 31 Global Musculoskeletal Disorders Drugs Market by Region, 2019 - 2022, USD Million
TABLE 32 Global Musculoskeletal Disorders Drugs Market by Region, 2023 - 2029, USD Million
TABLE 33 North America Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 34 North America Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 35 North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 37 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 41 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 44 North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 45 North America Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 46 North America Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 47 North America Oral Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Oral Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 50 North America Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 51 North America Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 52 North America Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 53 North America DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 54 North America DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 61 US Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 62 US Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 63 US Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 US Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 65 US Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 US Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 67 US Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 68 US Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 69 Canada Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 70 Canada Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 71 Canada Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 72 Canada Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 73 Canada Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 74 Canada Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 75 Canada Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 76 Canada Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 77 Mexico Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 78 Mexico Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 79 Mexico Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Mexico Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Mexico Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 82 Mexico Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 83 Mexico Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Mexico Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Rest of North America Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 86 Rest of North America Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 87 Rest of North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 88 Rest of North America Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 89 Rest of North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 90 Rest of North America Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 91 Rest of North America Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 92 Rest of North America Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 93 Europe Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 94 Europe Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 95 Europe Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 96 Europe Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 97 Europe Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 98 Europe Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 99 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 100 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 101 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 102 Europe Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 103 Europe Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 104 Europe Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 105 Europe Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 107 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Oral Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 110 Europe Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 111 Europe Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 115 Europe Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 116 Europe Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 117 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 121 Germany Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 122 Germany Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 123 Germany Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 124 Germany Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 125 Germany Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 126 Germany Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 127 Germany Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 128 Germany Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 129 UK Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 130 UK Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 131 UK Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 132 UK Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 133 UK Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 UK Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 135 UK Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 136 UK Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 137 France Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 138 France Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 139 France Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 France Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 141 France Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 142 France Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 143 France Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 144 France Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 145 Russia Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 146 Russia Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 147 Russia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 148 Russia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 149 Russia Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 150 Russia Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 151 Russia Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 152 Russia Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 153 Spain Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 154 Spain Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 155 Spain Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 156 Spain Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 157 Spain Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 158 Spain Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 159 Spain Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 160 Spain Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 161 Italy Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 162 Italy Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 163 Italy Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 164 Italy Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 165 Italy Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 166 Italy Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 167 Italy Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 168 Italy Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 169 Rest of Europe Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 170 Rest of Europe Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 171 Rest of Europe Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 172 Rest of Europe Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 173 Rest of Europe Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 174 Rest of Europe Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 175 Rest of Europe Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 176 Rest of Europe Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 177 Asia Pacific Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 178 Asia Pacific Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 179 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 180 Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 181 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 182 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 183 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 184 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 185 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 186 Asia Pacific Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 187 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 188 Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 189 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 190 Asia Pacific Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 191 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 192 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
TABLE 193 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 194 Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 195 Asia Pacific Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 196 Asia Pacific Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 197 Asia Pacific DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 198 Asia Pacific DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 199 Asia Pacific Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 200 Asia Pacific Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 205 China Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 206 China Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 207 China Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 208 China Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 209 China Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 210 China Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 211 China Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 212 China Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 213 Japan Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 214 Japan Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 215 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 216 Japan Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 217 Japan Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 218 Japan Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 219 Japan Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 220 Japan Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 221 India Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 222 India Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 223 India Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 224 India Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 225 India Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 226 India Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 227 India Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 228 India Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 229 South Korea Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 230 South Korea Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 231 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 232 South Korea Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 233 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 234 South Korea Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 235 South Korea Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 236 South Korea Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 237 Singapore Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 238 Singapore Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 239 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 Singapore Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 241 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 242 Singapore Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 243 Singapore Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 244 Singapore Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 245 Malaysia Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 246 Malaysia Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 247 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 248 Malaysia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 249 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 250 Malaysia Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 251 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 252 Malaysia Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 253 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 254 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 255 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 256 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 257 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 258 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 259 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 260 Rest of Asia Pacific Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 261 LAMEA Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 262 LAMEA Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 263 LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 264 LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 265 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 266 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 267 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 268 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 269 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 270 LAMEA Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 271 LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 272 LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 273 LAMEA Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 274 LAMEA Parenteral Market by Country, 2023 - 2029, USD Million
TABLE 275 LAMEA Oral Market by Country, 2019 - 2022, USD Million
TABLE 276 LAMEA Oral Market by Country, 2023 - 2029, USD Million
TABLE 277 LAMEA Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 278 LAMEA Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 279 LAMEA Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 280 LAMEA Analgesics Market by Country, 2023 - 2029, USD Million
TABLE 281 LAMEA DMARDs Market by Country, 2019 - 2022, USD Million
TABLE 282 LAMEA DMARDs Market by Country, 2023 - 2029, USD Million
TABLE 283 LAMEA Corticosteroids Market by Country, 2019 - 2022, USD Million
TABLE 284 LAMEA Corticosteroids Market by Country, 2023 - 2029, USD Million
TABLE 285 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 286 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 287 LAMEA Musculoskeletal Disorders Drugs Market by Country, 2019 - 2022, USD Million
TABLE 288 LAMEA Musculoskeletal Disorders Drugs Market by Country, 2023 - 2029, USD Million
TABLE 289 Brazil Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 290 Brazil Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 291 Brazil Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 292 Brazil Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 293 Brazil Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 294 Brazil Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 295 Brazil Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 296 Brazil Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 297 Argentina Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 298 Argentina Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 299 Argentina Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 300 Argentina Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 301 Argentina Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 302 Argentina Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 303 Argentina Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 304 Argentina Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 305 UAE Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 306 UAE Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 307 UAE Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 308 UAE Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 309 UAE Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 310 UAE Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 311 UAE Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 312 UAE Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 313 Saudi Arabia Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 314 Saudi Arabia Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 315 Saudi Arabia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 316 Saudi Arabia Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 317 Saudi Arabia Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 318 Saudi Arabia Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 319 Saudi Arabia Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 320 Saudi Arabia Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 321 South Africa Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 322 South Africa Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 323 South Africa Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 324 South Africa Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 325 South Africa Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 326 South Africa Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 327 South Africa Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 328 South Africa Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 329 Nigeria Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 330 Nigeria Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 331 Nigeria Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 332 Nigeria Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 333 Nigeria Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 334 Nigeria Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 335 Nigeria Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 336 Nigeria Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 337 Rest of LAMEA Musculoskeletal Disorders Drugs Market, 2019 - 2022, USD Million
TABLE 338 Rest of LAMEA Musculoskeletal Disorders Drugs Market, 2023 - 2029, USD Million
TABLE 339 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 340 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 341 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 342 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 343 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 344 Rest of LAMEA Musculoskeletal Disorders Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 345 Key information –Johnson & Johnson
TABLE 346 Key Information – Pfizer, Inc.
TABLE 347 Key information – AbbVie, Inc.
TABLE 348 Key Information – UCB S.A.
TABLE 349 Key Information – Amgen, Inc.
TABLE 350 Key Information – Eli Lilly And Company
TABLE 351 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 352 KEY INFORMATION - Merck & Co., Inc.
TABLE 353 Key Information – Novartis AG
TABLE 354 Key Information – Teva Pharmaceuticals Industries Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Global Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2022
FIG 5 Global Musculoskeletal Disorders Drugs Market Share by Distribution Channel, 2029
FIG 6 Global Musculoskeletal Disorders Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 7 Global Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2022
FIG 8 Global Musculoskeletal Disorders Drugs Market Share by Route of Administration, 2029
FIG 9 Global Musculoskeletal Disorders Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 10 Global Musculoskeletal Disorders Drugs Market Share by Drug Type, 2022
FIG 11 Global Musculoskeletal Disorders Drugs Market Share by Drug Type, 2029
FIG 12 Global Musculoskeletal Disorders Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 13 Global Musculoskeletal Disorders Drugs Market Share by Region, 2022
FIG 14 Global Musculoskeletal Disorders Drugs Market Share by Region, 2029
FIG 15 Global Musculoskeletal Disorders Drugs Market by Region, 2019 - 2029, USD Million
FIG 16 SWOT analysis: Johnson & Johnson
FIG 17 Recent strategies and developments: Pfizer, Inc.
FIG 18 Recent strategies and developments: AbbVie, Inc.